According to all the above evidence, we found LAMC2 could be the major factor influencing the median survival time of PC patients through combinatorial analysis of RUNX2 and LAMC2 (Figure 6F and Supplementary Tables 1, 2). The gene discussed is RUNX2; the disease is pachyonychia congenita.